Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Behavioral Treatments.

Gary J. Tucker1, Richard B. Stuart

  • 1Department of Psychiatry, University of Washington, 9429 45th Avenue, NE, Seattle, WA 98195, USA. laurann@u.washington.edu

Current Treatment Options in Neurology
|October 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Change in Cognitive Performance Accompanying Bilateral ECT.

Convulsive therapy·1985
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Behavioral therapy offers a non-pharmacologic approach to manage behavioral symptoms in patients with central nervous system damage. This method improves patient quality of life and caregiver involvement without medication side effects.

Area of Science:

  • Neurology
  • Behavioral Science

Background:

  • Central nervous system (CNS) disorders frequently cause emotional and behavioral disturbances.
  • These disturbances impact patient-environment interactions and the quality of care received.
  • Current pharmacologic treatments for CNS-related behavioral symptoms have limitations, including side effects and drug interactions.

Purpose of the Study:

  • To highlight the benefits of behavior therapy as a non-pharmacologic intervention for managing behavioral and emotional symptoms in individuals with CNS damage.
  • To present behavior therapy as a viable alternative or supplement to psychopharmacologic agents.

Main Methods:

  • Behavioral interventions are non-pharmacologic, avoiding drug interactions and side effects.
  • Treatments are tailored to specific symptoms, aiming to improve patient and caregiver quality of life.

Related Experiment Videos

  • Intervention success is quantifiable through pinpointing and measuring target behaviors.

    • Main Results:

    • Behavioral treatments are cost-effective, adaptable for administration by caregivers.
    • Caregiver involvement in behavioral treatment enhances their sense of participation and control.
    • Behavioral therapy is an effective complementary component in managing neurologic disorders.

    Conclusions:

    • Behavior therapy is a valuable, non-pharmacologic strategy for addressing behavioral and emotional disturbances associated with CNS damage.
    • It offers a safe, effective, and quantifiable approach to improving care quality for brain-damaged individuals.
    • Integrating behavioral treatments enhances patient outcomes and caregiver empowerment in clinical settings.